Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGA| |GGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCT
End
178461846/177597118 (Hg38)
Nearest miRNA
hsa-mir-10b/Upstream/283236; hsa-mir-1244-1/Downstream/2263718;
Upstream sequence
GTCTATTAAGAATGAAACACCACCCTGGAGGCTACAACCTTTACAAGGTCTGTGTTTCTTCTCCAAAAAATAAAAAGAACAAAGTCACCACTCTCCTCTC
Downstream sequence
TCAACTGGAGGAAAACTCAGTAGAAACTCAACACTCTTTTTCAGTGAGAAATACCTGATGTCATATATTTTGTTTAATAAAGACTGAATTGGCTGTACAC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.